Headache as a Prognostic Factor for COVID-19. Time to Re-evaluate
Paolo Martelletti, Enrico Bentivegna, Michelangelo Luciani, Valerio Spuntarelli
Abstract
Headache occurs in only about 13% of patients within the cohort of presenting COVID-19 symptoms. The hypothesis that such a painful symptomatic picture could be considered a prognostic factor for COVID-19 positive evolution or its trend of severity, or the co-generation of hyposmia/anosmia and/or hypogeusia/ageusia, needs robust epidemiological data, punctual pathophysiological demonstrations, and a detailed comparative analysis on drug-drug interactions (DDIs).
Topics & Concepts
AnosmiaHyposmiaCoronavirus disease 2019 (COVID-19)MedicineEpidemiologyCohortRisk factorSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakInternal medicineDiseasePathologyOutbreakInfectious disease (medical specialty)Long-Term Effects of COVID-19Olfactory and Sensory Function StudiesRetinal and Optic Conditions